Skip to main content

Posts

Featured

Engineering the Future of Medicine: Translational Innovation with Global Visionary Prof. Donald E. Ingber

Prof. Donald E. Ingber Announced as Plenary Speaker at InnoPharm-2026 |  Boston, MA We are proud to announce Prof. Donald E. Ingber,  Founding Director and Core Faculty of the Wyss Institute for Biologically Inspired Engineering at Harvard University , as a Plenary Speaker at InnoPharm-2026. A world-renowned scientist, innovator, and thought leader, Prof. Ingber has fundamentally reshaped how biology, engineering, and medicine converge to drive real-world impact.   With decades of groundbreaking contributions, Prof. Ingber is internationally recognized for pioneering work in mechanobiology, organ-on-chip technology, and biologically inspired engineering. His research has transformed our understanding of how physical forces and microenvironmental cues regulate cell behavior, disease progression, and therapeutic response-opening entirely new pathways for drug discovery, disease modeling, and precision medicine.   As the founding director of the Wyss Institute at Harvar...

Latest Posts

Next-Generation Clinical Trials & Translational Research to Take Center Stage at InnoPharm-2026

AI is redefining pharma in 2026.

How It Works at InnoPharm-2026 — And Why Researchers Choose Us

New year. New momentum. New science. InnoPharm Session Highlight

Second International Conference on Innovations in Pharma R&D | Boston

Glimpse of InnoPharm-2025 😊

Meet the Plenary & Keynote Speakers of InnoPharm-2025

Drug Discovery Session Chair

Targeting the Untargeted: GPCRomics in Cancer Innovation

From Lab to Life: The Future of PK/PD with Global Pioneer Prof. Leslie Benet